Aviva’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.9M Buy
316,559
+6,036
+2% +$1.67M 0.1% 178
2026
Q1
$91.7M Buy
310,523
+8,817
+3% +$2.62M 0.15% 126
2025
Q4
$82.4M Buy
301,706
+15,900
+6% +$4.32M 0.14% 142
2025
Q3
$77.2M Buy
285,806
+16,395
+6% +$4.46M 0.14% 141
2025
Q2
$74.3M Buy
269,411
+65,369
+32% +$17.8M 0.15% 138
2025
Q1
$54.1M Buy
204,042
+28,168
+16% +$6.95M 0.13% 174
2024
Q4
$40.8M Sell
175,874
-8,997
-5% -$2.07M 0.11% 207
2024
Q3
$40.8M Buy
184,871
+4,422
+2% +$915K 0.11% 236
2024
Q2
$35.5M Buy
180,449
+31,579
+21% +$6.52M 0.1% 238
2024
Q1
$32.1M Buy
148,870
+10,717
+8% +$2.25M 0.11% 229
2023
Q4
$29.1M Sell
138,153
-8,874
-6% -$1.89M 0.1% 234
2023
Q3
$29.4M Buy
147,027
+14,313
+11% +$2.85M 0.12% 193
2023
Q2
$24.6M Sell
132,714
-60,315
-31% -$11.1M 0.1% 244
2023
Q1
$37M Buy
193,029
+31,180
+19% +$5.64M 0.17% 149
2022
Q4
$27.2M Buy
161,849
+18,139
+13% +$3.15M 0.13% 195
2022
Q3
$25.5M Buy
143,710
+18,926
+15% +$3.74M 0.15% 171
2022
Q2
$25.5M Buy
124,784
+19,310
+18% +$4.09M 0.14% 181
2022
Q1
$25.1M Sell
105,474
-8,263
-7% -$1.94M 0.13% 180
2021
Q4
$26M Buy
113,737
+4,000
+4% +$880K 0.11% 183
2021
Q3
$21.2M Sell
109,737
-15,702
-13% -$3.18M 0.09% 211
2021
Q2
$26.7M Buy
125,439
+7,093
+6% +$1.5M 0.12% 184
2021
Q1
$24.2M Sell
118,346
-79
-0.1% -$15.6K 0.12% 171
2020
Q4
$21.6M Buy
118,425
+3,794
+3% +$645K 0.11% 180
2020
Q3
$19.2M Sell
114,631
-3,310
-3% -$558K 0.11% 163
2020
Q2
$19.2M Sell
117,941
-6,547
-5% -$1.17M 0.12% 151
2020
Q1
$21.5M Sell
124,488
-46,473
-27% -$9.25M 0.16% 118
2019
Q4
$34.3M Sell
170,961
-712
-0.4% -$146K 0.21% 101
2019
Q3
$36.3M Sell
171,673
-46,177
-21% -$9.65M 0.25% 92
2019
Q2
$42.3M Sell
217,850
-85,524
-28% -$15.8M 0.29% 78
2019
Q1
$49.9M Sell
303,374
-7,372
-2% -$1.3M 0.34% 74
2018
Q4
$58.5M Buy
310,746
+146,387
+89% +$27M 0.44% 59
2018
Q3
$28M Sell
164,359
-6,053
-4% -$1.02M 0.15% 145
2018
Q2
$27.9M Sell
170,412
-36
-0% -$5.88K 0.16% 138
2018
Q1
$27.6M Sell
170,448
-13,502
-7% -$2.15M 0.17% 135
2017
Q4
$26.9M Sell
183,950
-26,627
-13% -$3.79M 0.15% 152
2017
Q3
$28.6M Buy
210,577
+4,738
+2% +$599K 0.15% 154
2017
Q2
$25.8M Buy
205,839
+7,770
+4% +$929K 0.14% 164
2017
Q1
$23.5M Sell
198,069
-11,030
-5% -$1.33M 0.13% 169
2016
Q4
$24.1M Buy
209,099
+13,482
+7% +$1.5M 0.14% 158
2016
Q3
$20.4M Buy
195,617
+4,438
+2% +$463K 0.13% 191
2016
Q2
$18.6M Sell
191,179
-3,316
-2% -$313K 0.13% 187
2016
Q1
$18.7M Buy
194,495
+10,034
+5% +$913K 0.14% 160
2015
Q4
$16.7M Sell
184,461
-1,235
-0.7% -$116K 0.13% 174
2015
Q3
$17.2M Sell
185,696
-229,418
-55% -$21.8M 0.14% 167
2015
Q2
$38.6M Sell
415,114
-74,830
-15% -$6.98M 0.27% 85
2015
Q1
$46.4M Buy
489,944
+4,013
+0.8% +$372K 0.32% 70
2014
Q4
$43.1M Sell
485,931
-18,413
-4% -$1.56M 0.33% 73
2014
Q3
$40.3M Sell
504,344
-98,259
-16% -$7.4M 0.32% 69
2014
Q2
$42.8M Sell
602,603
-60,225
-9% -$4.24M 0.33% 69
2014
Q1
$49.1M Sell
662,828
-32,702
-5% -$2.47M 0.4% 57
2013
Q4
$54.6M Buy
695,530
+34,240
+5% +$2.68M 0.46% 52
2013
Q3
$48.9M Buy
661,290
+1,171
+0.2% +$86.3K 0.43% 49
2013
Q2
$50.2M Buy
+660,119
New +$43.3M 0.51% 44

Other funds holding CME

Aviva's CME Position: Q2 2026 in Review

Aviva increased its CME Group (CME) stake by 1.9% in Q2 2026, buying an estimated $1.67M and bringing the position to 316,559 shares worth $69.9M. The position accounts for 0.1% of the portfolio, ranked #178.

Aviva first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $91.7M in Q1 2026. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Aviva held 316,559 shares of CME Group worth $69.9M as of Q2 2026.
  • Aviva bought 6,036 CME Group shares in Q2 2026, an estimated $1.67M.
  • CME Group made up 0.1% of Aviva's portfolio in Q2 2026, its #178 holding.
  • Aviva first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Aviva's CME Group position peaked at $91.7M in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.